Support First Things by turning your adblocker off or by making a  donation. Thanks!

In The Stem Cell Banking Crisis , The Scientist reports that

The National Institutes of Health (NIH) has allowed a contract for the dissemination of embryonic stem cell lines approved for US government funding to lapse, shuttering a key stem cell bank, and doubling the price researchers pay for samples of some human embryonic stem cell (hESC) line . . . from $500 per vial of frozen cells to $1,000.

The rest of the article describes the problem and implies the need for the government to distribute the lines and subsidize the sales as well.

Leaving aside how disturbing it is to find these Inception (2010) cells treated as a commodity, given their origin and use, why should the government — meaning you and me, through our tax dollars — be involved at all? Just practically speaking: if these cells will do everything promised, why haven’t businesses set themselves up to distribute them and why should the sales be subsidized given what profits the research will (we’ve been told over and over) bring?

00 Days
00 Hours
00 Minutes
00 Seconds
Dear Reader,

Your charitable support for First Things is urgently needed before the clock above hits zero.

First Things is proud to be a reader-supported enterprise, and the Spring Campaign is one of only two major reader giving drives each year. It ends on June 30 at 11:59 p.m.

Your gift will fortify First Things to speak boldly on behalf of religious voices in the public square ahead of a pivotal season for our nation and the church.

Please give now.

Make My Gift

Comments are visible to subscribers only. Log in or subscribe to join the conversation.



Filter First Thoughts Posts

Related Articles